Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM.
Saved in:
| Title: | Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM. |
|---|---|
| Authors: | Merz LE; University of Michigan Medical School, Ann Arbor, MI., Perissinotti AJ; Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI., Marini BL; Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI., Burke PW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Crouch A; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Erba HP; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC., Bixby D; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI. Electronic address: dbixby@med.umich.edu. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Jan; Vol. 20 (1), pp. 24-30. Date of Electronic Publication: 2019 Sep 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31711889 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Merz+LE%22">Merz LE</searchLink>; University of Michigan Medical School, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Perissinotti+AJ%22">Perissinotti AJ</searchLink>; Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Marini+BL%22">Marini BL</searchLink>; Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Burke+PW%22">Burke PW</searchLink>; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Crouch+A%22">Crouch A</searchLink>; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Erba+HP%22">Erba HP</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Bixby+D%22">Bixby D</searchLink>; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI. Electronic address: dbixby@med.umich.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2020 Jan; Vol. 20 (1), pp. 24-30. <i>Date of Electronic Publication: </i>2019 Sep 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31711889 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clml.2019.09.615 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 24 Titles: – TitleFull: Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Merz LE – PersonEntity: Name: NameFull: Perissinotti AJ – PersonEntity: Name: NameFull: Marini BL – PersonEntity: Name: NameFull: Burke PW – PersonEntity: Name: NameFull: Crouch A – PersonEntity: Name: NameFull: Erba HP – PersonEntity: Name: NameFull: Bixby D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2020 Jan Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 20 – Type: issue Value: 1 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |
